Anti-MYH7 monoclonal antibody

Pre-made anti-MYH7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MYH7/MYH7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T07507-Ab-1/ GM-Tg-hg-T07507-Ab-2Anti-Human MYH7 monoclonal antibodyHuman
GM-Tg-rg-T07507-Ab-1/ GM-Tg-rg-T07507-Ab-2Anti-Rat MYH7 monoclonal antibodyRat
GM-Tg-mg-T07507-Ab-1/ GM-Tg-mg-T07507-Ab-2Anti-Mouse MYH7 monoclonal antibodyMouse
GM-Tg-cynog-T07507-Ab-1/ GM-Tg-cynog-T07507-Ab-2Anti-Cynomolgus/ Rhesus macaque MYH7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T07507-Ab-1/ GM-Tg-felg-T07507-Ab-2Anti-Feline MYH7 monoclonal antibodyFeline
GM-Tg-cang-T07507-Ab-1/ GM-Tg-cang-T07507-Ab-2Anti-Canine MYH7 monoclonal antibodyCanine
GM-Tg-bovg-T07507-Ab-1/ GM-Tg-bovg-T07507-Ab-2Anti-Bovine MYH7 monoclonal antibodyBovine
GM-Tg-equg-T07507-Ab-1/ GM-Tg-equg-T07507-Ab-2Anti-Equine MYH7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T07507-Ab-1/ GM-Tg-hg-T07507-Ab-2; GM-Tg-rg-T07507-Ab-1/ GM-Tg-rg-T07507-Ab-2;
GM-Tg-mg-T07507-Ab-1/ GM-Tg-mg-T07507-Ab-2; GM-Tg-cynog-T07507-Ab-1/ GM-Tg-cynog-T07507-Ab-2;
GM-Tg-felg-T07507-Ab-1/ GM-Tg-felg-T07507-Ab-2; GM-Tg-cang-T07507-Ab-1/ GM-Tg-cang-T07507-Ab-2;
GM-Tg-bovg-T07507-Ab-1/ GM-Tg-bovg-T07507-Ab-2; GM-Tg-equg-T07507-Ab-1/ GM-Tg-equg-T07507-Ab-2
Products NameAnti-MYH7 monoclonal antibody
Formatmab
Target NameMYH7
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MYH7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T07507-Ag-1Recombinant multi-species MYH7/ CMD1S/ CMH1 protein


    Target information

    Target IDGM-T07507
    Target NameMYH7
    Gene ID4625,140781,403807,101096736,791234
    Gene Symbol and SynonymsB-MHC,beta-MHC,betaMHC,CMD1S,CMH1,CMYP7A,CMYP7B,MPD1,MYH-beta/slow,MYH7,MyHC-alpha,Myhc-b,myHC-beta,MyHC-I,myHC-slow,MYHCB,MyHCS,SPMD,SPMM
    Uniprot AccessionP12883,P49824,Q8MJU9
    Uniprot Entry NameMYH7_HUMAN,MYH7_CANLF,MYH7_HORSE
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseHeart failure, Congenital occlusion of ureteropelvic junction
    Gene EnsemblENSG00000092054
    Target ClassificationN/A

    The target: MYH7, gene name: MYH7, also named as CMD1S, CMH1, MPD1, MYHCB, SPMD, SPMM. Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing distal myopathy. [provided by RefSeq, May 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.